Company Overview of aTyr Pharma Inc.
aTyr Pharma Inc., a protein therapeutics company, engages in the discovery and development of biologic therapeutics based on physiocrines. It focuses on the discovery of phyisiocrines, which are a class of endogenous human proteins from amino acyl tRNA synthetases that function as extracellular signaling molecules in various physiologic settings; and the development of physiocrine-based medicines for indications in the areas of hematology, immune modulation, infection, and metabolism. The company’s lead product is Tmax, which is in preclinical development for thrombocytopenia. aTyr Pharma Inc. was incorporated in 2005 and is based in San Diego, California.
3565 General Atomics Court
San Diego, CA 92121
Founded in 2005
Key Executives for aTyr Pharma Inc.
aTyr Pharma Inc. Key Developments
Similar Private Companies By Industry
|LifeStem, Inc.||United States|
|Ciphergen Technologies, Inc.||United States|
|Laser Pharma Inc.||United States|
|Verax Biomedical, Incorporated||United States|
Recent Private Companies Transactions
July 29, 2013
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- San Francisco, CA | Investment Firm Providing Private and Institutional BrokeragePosted: Apr 07
- Gaithersburg, MD | MedimmunePosted: Apr 16
- San Mateo, CA |Posted: Apr 05
- New York | Shore ConsultantsPosted: Apr 14
Sponsored Financial Commentaries
To contact aTyr Pharma Inc., please visit www.atyrpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.